The Evidence for Contraceptive Options and HIV Outcomes Trial
Status:
Completed
Trial end date:
2018-10-31
Target enrollment:
Participant gender:
Summary
The ECHO Study is an open-label randomized clinical trial that will compare three highly
effective, reversible methods of contraception (including a non-hormonal method) to evaluate
whether there is a link between use of any of these methods and increased risk of acquiring
HIV infection. A randomized clinical trial among about 7,800 women in four countries, ECHO
will deliver evidence to support and guide individual, policy and programmatic decisions on
contraception for women at risk of acquiring HIV infection.
Phase:
N/A
Details
Lead Sponsor:
FHI 360
Collaborators:
Effective Care Research Unit Emavundleni Research Centre Family Life Association of Swaziland ICAP Columbia University Kenya Medical Research Institute Madibeng Centre for Research Maternal Adolescent and Child Health Research Qhakaza Mbokodo Research Clinic Setshaba Research Centre The Aurum Institute NPC University of North Carolina at Chapel Hill Division of Global Women’s Health University of North Carolina, Chapel Hill University of Washington Wits Reproductive Health and HIV Institute World Health Organization